REFERENCES
- Andreopoulos A. G., Tarantili P. A. Xanthan gum as a carrier for controlled release of drugs. J. Biomat. Appl. 2001; 16: 34–46
- Bhardwaj T. R., Kanwar M., Roshan Lal, Gupta A. Natural gums and modified natural gums as sustained-release carriers. Drug Dev. Ind. Pharm. 2000; 26: 1025–1038
- Challa R., Ahuja A., Javed Ali, Khar R. K. Cyclodextrins in drug delivery: An updated review. AAPS Pharm Sci Tech. 2005; 6: 329–357
- Chourasia M. K., Jain S. K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm Pharm Sci. 2003; 6: 33–66
- Goldstein A. M., Alter E. N., Seaman J. K. Guar Gum. Industrial Gums, Polysaccharides and their Derivatives, R. L. Whistler. Academic Press, New York 1973; 303–321
- Jain N. K., Chourasia M. K., Jain S. K. Development and characterization of engineered commensal bacteria for the delivery of enzymes. Ind. J. Pharm. Sci. 2003; 65: 113–121
- Khan M. Z., Prebeg Z., Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit L100-55 and Eudragit S100 combinations. J. Control. Rel. 1999; 58: 215–222
- Kim H., Fassihi R. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. diltiazem hydrochloride. Pharm. Res. 1997; 4: 1415–1421
- Kosaraju S. L. Colon Targeted Delivery Systems: Review of polysaccharides for encapsulation and delivery. Crit. Rev. Food Sci. Nut. 2005; 45: 251–258
- Lau A. H., Lam N. P., Piscitelli I., Danziger L. H. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infective agents. Clin. Pharmacokinetics. 1992; 23L: 328–364
- Lapidus H., Lordi N. G. Drug release from compressed hydrophilic matrices. J. Pharm. Sci. 1968; 57: 1292–1301
- Marcos B. P., Gutierrez C., Gomez-Amoza J. L., Martinez Pacheco R., Souto C., Concheiro A. Usefulness of certain varieties of carbomer in the formulation of hydrophilic furosemide matrices. Int. J. Pharm. 1991; 67: 113–119
- McCoy J. J., Mann B. J., Petri W. A., Jr. Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect. Immun. 1994; 62: 3045–3050
- Mundargi R. C., Agnihotri S. A., Pati l. S. A., Aminabhavi T. M. Graft copolymerization of methacrylic acid onto guar gum using potassium persulfate as an initiator. J. Appl. Polym. Sci. 2006; 101: 618–623
- Rama Prasad Y. V., Krishnaiah Y. S. R., Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J. Control. Rel. 1998; 51: 281–287
- Reddy S. M., Sinha V. R., Reddy D. S. Novel oral colon specific drug delivery systems for pharmacotherapy of peptide and non-peptide drugs. Drugs Today 1999; 35: 537–580
- Ritger P., Peppas N. A simple equation for description of solute release II: Fickian and anomalous release from swellable devices. J. Control. Rel. 1987; 5: 37–42
- Rubinstein A. Microbially controlled drug delivery to the colon. Biopharm. Drug Disp. 1990; 11: 465–475
- Rubinstein A., Radai R., Ezra M, Pathak S., Rokem S. In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier. Pharm. Res. 1993; 10: 258–263
- Sinha V. R., Kumria R. Binders for colon specific drug delivery: an in vitro evaluation. Int. J. Pharm. 2002; 249: 23–31
- Takka S., Dcak D. H., Acarturk F. Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies. Eur. J. Pharm. Biopharm. 1998; 6: 241–246
- Talukdar M. M., Kinget R. Swelling and drug release behavior of xanthan gum matrix tablets. Drug Dev. Ind. Pharm. 1995; 120: 63–72
- Toti U. S., Aminabhavi T. M. Modified guar gum matrix tablet for controlled release of diltiazem hydrochloride. J. Control. Rel. 2004; 95: 567–577
- Tracy J. W., Webster L. T. Drugs used in the chemotherapy of protozoal infections. The Pharmacological Basis of Therapeutics9th, A. G. Goodman, Gilman. McGraw Hill, New York 1996; 995–998, and 1012–1015.
- Tugcu-Demiroz F., Acarturk F., Takka S., Konus-Boyunaga O. In vitro and in vivo evaluation of mesalazine–guar gum matrix tablets for colonic drug delivery. J. Drug Targ. 2004; 12: 105–112
- Upadrashta S. M., Katikaneni P. R., Nuessle N. O. Chitosan as a tablet binder. Drug Dev. Ind. Pharm. 1992; 18: 1701–1708
- Vandamme T. F., Lenourry A., Charrueau C., Chaumeil J. C. The use of polysaccharides to target drugs to the colon. Carb. Polym. 2002; 48: 219–231
- Vanden Mooter G., Samyn C., Kinget R. Azo polymers for colon-specific drug delivery. Part II: influence of the type of azo polymer on the degradation by intestinal microflora. Int. J. Pharm. 1993; 97: 133–139
- Wakerly Z., Fell J. T., Attwood D., Parkins D. A. In vitro evaluation of pectin-based colonic drug delivery systems. Int. J. Pharm. 1996; 129: 73–77
- Wilding I. R., Hardy J. G., Sparrow R. A., Davis S. S., Daly P. B., English J. R. In vivo evaluation of enteric coated naproxan tablets using gamma scintigraphy. Pharm. Res. 1992; 9: 1436–1441